6533b859fe1ef96bd12b75cc

RESEARCH PRODUCT

Effects of Administration of Glycoprotein IIb/IIIa Receptor Antagonists in Patients with Failed Thrombolysis

Francesco GiambancoGiuseppe CalcaterraBucca VincenzoPietro Di PasqualeFilippo M. SarulloSergio CannizzaroM.g. VitranoSalvatore PaternaAngela Scandurra

subject

chemistry.chemical_classificationmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentGeneral MedicineThrombolysisTirofibanmedicine.diseaseGastroenterologyPharmacotherapychemistryInternal medicinemedicineAbciximabEptifibatidePharmacology (medical)cardiovascular diseasesMyocardial infarctionGlycoproteinbusinessReceptormedicine.drug

description

Aim To evaluate the effectiveness of glycoprotein (GP) IIb/IIIa receptor antagonists in patients with acute myocardial infarction (AMI) who have undergone unsuccessful thrombolysis.

https://doi.org/10.2165/00044011-200121080-00003